We have posted an interesting Tech Note on methods to deal therapeutically with prostate cancer. These approaches have significant merit and may evolve rapidly
We note:
Prostate Cancer has been a challenging malignancy to treat. Surface molecules that uniquely identify PCa have been examined and combined with the multiplicity of targetable antibody therapies one may suspect several viable approaches may be evolving. We examine these in this Note. We present a protocol which allows one to take a path slide and determine optimum surface markers cell by cell and create targeted poly specific antibodies for optimal treatment.
This combined with treatments for the tumor micro environment are demonstrating how therapeutics are evolving. There is an interesting course at Harvard that those interest may look at.
Posts
